Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pathobiotek reports link between Leuy and MS (multiple sclerosis):

This article was originally published in Clinica

Executive Summary

Pathobiotek Diagnostics has reported promising preliminary results from a correlation study to assess the relationship between a bloodborne bacterium called Leuy and the symptoms of multiple sclerosis (MS) and other immune disorders. "The first few MS samples showed over 100 times the Leuys per millilitre when compared to normals," said the Houston, Texas company, which discovered the bacterium and which is developing tests for diseases associated with the agent. The results support data collected over the past eight years, but were produced using more sophisticated and accurate diagnostics, the company added.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel